Author
Listed:
- Mohammed Tarek Alam
(Bangladesh Medical College Hospital, Bangladesh)
- Rubaiul Murshed
(Shomman Foundation, Bangladesh)
- Pauline Francisca Gomes
(Shomman Foundation, Bangladesh)
- Zafor Md. Masud
(Bangladesh Medical College Hospital, Bangladesh)
- Sadia Saber
(Bangladesh Medical College Hospital, Bangladesh)
- Mainul Alam Chaklader
(Bangladesh Medical College Hospital, Bangladesh)
- Fatema Khanam
(Bangladesh Medical College Hospital, Bangladesh)
- Monower Hossain
(Bangladesh Medical College Hospital, Bangladesh)
- Abdul Basit Ibne Momen Momen
(Bangladesh Medical College Hospital, Bangladesh)
- Naz Yasmin
(International Medical College, Bangladesh)
- Rafa Faaria Alam
(Bangladesh Medical College Hospital, Bangladesh)
- Amrin Sultana
(Bangladesh Medical College Hospital, Bangladesh)
- Rishad Choudhury Robin
(Shomman Foundation, Bangladesh)
Abstract
Introduction: While multiple vaccines are undergoing clinical trial across the globe, we yearn for an FDA approved drug to protect us from the devastating pandemic for the time being. This study aims to determine the effectiveness of Ivermectin when administered as pre-exposure prophylaxis for COVID-19. Method: An observational study, with 118 healthcare providers who were enrolled purposively, was conducted in a tertiary hospital in Dhaka from May 2020 to August 2020. The subjects were divided into experimental and control groups; and the experimental group received an oral monthly dose of Ivermectin 12mg for 4 months. Both groups were exposed to COVID-19 positive patients admitted in the hospital during the course of study. The symptomatic subjects were evaluated by physical examination, COVID-19 RT-PCR and/or HRCT of chest. Differences between the variables were determined using the Chi-square test and the level of statistical significance was reached when p
Suggested Citation
Mohammed Tarek Alam & Rubaiul Murshed & Pauline Francisca Gomes & Zafor Md. Masud & Sadia Saber & Mainul Alam Chaklader & Fatema Khanam & Monower Hossain & Abdul Basit Ibne Momen Momen & Naz Yasmin & , 2020.
"Ivermectin as Pre-exposure Prophylaxis for COVID-19 among Healthcare Providers in a Selected Tertiary Hospital in Dhaka – An Observational Study,"
European Journal of Medical and Health Sciences, European Open Science, vol. 2(6), November.
Handle:
RePEc:epw:ejmed0:v:2:y:2020:i:6:id:40599
DOI: 10.24018/ejmed.2020.2.6.599
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:epw:ejmed0:v:2:y:2020:i:6:id:40599. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Support (email available below). General contact details of provider: https://eu-opensci.org/index.php/ejmed .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.